Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris International, which faced a yearslong decline in cigarette smoking.

Shares of Philip Morris International Inc. extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine ...

Philip Morris delivered strong Q4 results, surpassing EPS and revenue estimates, driven by surging demand for non-traditional products like IQOS and ZYN. Non-traditional products now represent 40% ...

Philip Morris International PM0.96%increase; green up pointing triangle posted higher-than-expected revenue in its fourth quarter, signaling its Zyn nicotine pouches continue to power results.

“making ZYN the first and only authorized nicotine pouch in the United States,” announced Swedish Match, a subsidiary of Philip Morris (PM) International. “The FDA’s authorization of all ...

Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.

FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris International Inc. extended their recent ...